Global Cannabis Applications Corp (GCAC) (CSE:APP, FRA:2FA, OTCQB:FUAPF), a leading developer of innovative data technologies for the cannabis industry, is pleased to announce that Global Cannabis Apps Corporation (Australia) Pty. Ltd. (“GCAC Australia”), the Company’s 61% subsidiary in Australia, has secured an exclusive global license for Medical Cannabis Artificial Intelligence (“AI”) regulation technology with Australian-based Compliance Master International (“CMI”).
GCAC Australia will hold the exclusive global usage and distribution rights to ‘Cannabis Compliance AI’ – a cutting edge AI risk-based auditing and inspection technology to be rolled out to the global medical cannabis industry.
“We are very excited to be working with GCAC on this venture,” said CMI’s founder and Chief Executive Officer Peter Mills, who is a highly regarded Australian data scientist. “In particular, we see this as an unparalleled opportunity to establish our world-leading technology as the benchmark for managing regulatory risks in Australia and other countries with medical cannabis programs.”
One of the biggest challenges facing governments is establishing the necessary regulatory structures and processes needed to reliably monitor and control quality and supply-chain risks of medical cannabis, while reducing the costs and burden placed on cannabis product producers and the public at the same time.
“This is where our AI technology can be of significant benefit to the medical cannabis sector,” said Peter Mills. “Unlike other software solutions our risk-based auditing and inspection technology uses advanced statistical algorithms to quantitatively assess and control regulatory non-compliance risks within specified limits, or risk appetite. The software’s unique AI technology automatically focuses a producer’s limited monitoring and control activities on those areas of its operation that represent its highest risk exposure, while in-built data analytics significantly reduce the amount of time and effort needed to collect, analyze and report risk levels internally and externally – by up to 80%.”
Jason Webb, Chief Executive Officer of GCAC Australia says, “Our Cannabis Compliance AI is going to be transformative technology for the industry as it grows. Not only will it will help all participants from licensed producers to product producers monitor their regulatory requirements, it will save significant time and costs in regulation management, accelerate knowledge and facilitate unprecedented data sharing for the betterment of medical cannabis users.”
Brad Moore, Chief Executive Officer of GCAC states, “This technology will help cement GCAC as the go-to medical cannabis data company. At the front end, the AI will be extremely important in ensuring we collect the best data possible on products listed on our Prescriptii and CannaLife Apps. At the back end, the AI compliance technology will further help us establish our credentials as the most trusted source of data from regulator to retail.”
The ‘Cannabis Compliance AI’ will be a core component of the GCAC Blockchain and ICO. It is anticipated that the AI application will be very attractive to all spectrums of the medical cannabis industry and provide first revenue streams for GCAC Australia.
About Global Cannabis Applications Corp.
Global Cannabis Applications Corp. is a global leader in designing, developing, marketing, and acquiring innovative data technologies for the cannabis industry. Used globally, GCAC’s technologies facilitate the proliferation of digital conversations by like-minded people. Managed by digital and cannabis industry experts, GCAC is focused on viral global expansion by providing the best digital experience in the cannabis market.
For more information about the Company, please visit online at www.cannappscorp.com, or review its profiles on the SEDAR website (www.sedar.com and on the Canadian Securities Exchange’s website (www.thecse.com).
To schedule an interview, please contact:
Bradley Moore
Chief Executive Officer
Telephone: 514-5619091
Email: bmoore@cannappscorp.com
For more information, please contact:
Corporate Communications
Telephone: 1.855.269.9554
Email: info@cannappscorp.com
www.cannappscorp.com
Forward-Looking Information
This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.
Click here to connect with Global Cannabis Applications Corp (GCAC) (CSE:APP, FRA:2FA, OTCQB:FUAPF)) to receive an Investor Kit.

Source: www.thenewswire.com


Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) announces it has completed a first closing of a non-brokered private placement of up to $2,000,000. The Company accepted subscriptions for 13,740,000 units at a price of $0.05 per unit, for gross proceeds of $687,000. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at $0.075 for a period of two years from the date of closing, subject to the option of the Company to accelerate the expiry date in the event that its shares trade at $0.15 or more for 10 consecutive days

The Company paid $18,000 in cash and issued 160,000 warrants on the same terms as noted above to qualified finders. Securities issued pursuant to this tranche are subject to trading restrictions until April 5, 2021. The Company is expecting to complete the financing by December 16, 2020. Proceeds will be used for working capital and to fund future investments.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press release dated December 3, 2020, the TSX Venture Exchange has approved the repricing of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.

For anybody wishing to exercise these Warrants, please contact the Chief Executive Officer, Terry Donnelly at the particulars below.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Aurora Cannabis (NYSE: ACB) (TSX: ACB), and HEXO Corp. (NYSE: HEXO)

Cannabis leaders are focusing on innovation in premium branding, global expansion, and tight operational execution in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders:

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has closed the 2nd and final tranche of its Unit financing. In connection with the closing, the Company issued 1,356,873 Units at a price of $0.55 per Unit, for gross proceeds of $746,280.15. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on) is equal to or greater than $1.25 for a period of 20 consecutive trading days. Finder’s fees of $42,542, 3,200 Finder’s shares and 80,550 Finder’s warrants were issued in connection with finder’s fees payable.

In total, the Company raised gross proceeds of $1,757,180 and issued 3,194,873 Units.

Keep reading... Show less

 Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) (“Sweet Earth” the “Company”) is pleased to announce that it has received full Depository Trust Company (“DTC”) eligibility in the United States. On October 20, 2020, Sweet Earth announced that its shares had been listed on the United States’ Over-The-Counter Bulletin (“OTCQB”) under the ticker SEHCF.

DTC status means that Sweet Earth shares are now eligible to be transferred between brokerage accounts within the United States and significantly augments the ease in which American-based investors are able to trade Sweet Earth shares.

Keep reading... Show less